Clinical Trials Directory

Trials / Unknown

UnknownNCT04910620

The Evaluation of TCI378 and TCI507 Probiotics on Weight-lowering Efficacy in Adults

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
96 (estimated)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Obesity is a serious global public health issue. Many reports have showed that the use of appropriate probiotics can bring benefits to the health of the host and promote the balance of gut microbiota. Clinical experimental data show that the supplement of probiotics can help regulate gut function and weight control, and etc. TCI378 (Lactobacillus plantarum TCI378) is a probiotic extracted from Korean kimchi, and TCI507 (Lactobacillus plantarum TCI507) is a probiotic extracted from the oranges peels. These two strains of probiotics have been verified by in vitro experiments to have the effect of hydrolyzing bile salts, inhibition of the production of fat cells. Therefore, we want to evaluate whether the probiotics TCI308 and TCI507 have effects on reduction of body weight.

Conditions

Interventions

TypeNameDescription
DRUGPlaceboPlacebo only
DRUGTCI378TCI378 (Lactobacillus plantarum TCI378)
DRUGTCI507TCI507 (Lactobacillus plantarum TCI507)

Timeline

Start date
2021-06-15
Primary completion
2024-06-14
Completion
2024-06-14
First posted
2021-06-02
Last updated
2021-06-02

Source: ClinicalTrials.gov record NCT04910620. Inclusion in this directory is not an endorsement.